Targeting the glucagon receptor improves cardiac function and enhances insulin sensitivity following a myocardial infarction
2019
Background
In heart failure the myocardium becomes insulin resistant which negatively influences cardiac energy metabolism and function, while increasing cardiac insulin signalling improves cardiac function and prevents adverse remodelling in the failing heart. Glucagon’s action on cardiac glucose and lipid homeostasis counteract that of insulin’s action. We hypothesised that pharmacological antagonism of myocardial glucagon action, using a human monoclonal antibody (mAb A) against glucagon receptor (GCGR), a G-protein coupled receptor, will enhance insulin sensitivity and improve cardiac energy metabolism and function post myocardial infarction (MI).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
65
References
38
Citations
NaN
KQI